A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Study Identifier:
C09-001r
ClinicalTrials.gov Identifier:
NCT01770951
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Aug 2009 - Nov 2010
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Aug 2009 - Nov 2010
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.

      Trial Locations

      Location
      Status
      Location
      Dunwoody, Georgia, United States
      Status
      N/A
      Location
      Chicago, Illinois, United States
      Status
      N/A
      Location
      Portland, Maine, United States
      Status
      N/A
      Location
      Boston, Massachusetts, United States
      Status
      N/A
      Location
      Durham, North Carolina, United States
      Status
      N/A
      Location
      Cincinnati, Ohio, United States
      Status
      N/A